baber/WOPTO huggingface dataset:
Patent NZ-249808-A (NZ)
Title: Genetic sequence encoding flavonoid pathway enzymes and their uses
Inventor: HOLTON TIMOTHY ALBERT
IPC: C12Q1/68
Filed: 1993-03-25
Abstract: PCT No. PCT/AU93/00127 Sec. 371 Date Nov. 30, 1994 Sec. 102(e) Date Nov. 30, 1994 PCT Filed Mar. 25, 1993 PCT Pub. No. WO93/20206 PCT Pub. Date Oct. 14, 1993The present invention relates to a nucleic acid isolate comprising a sequence of nucleotides encoding, or complementary to a sequence encoding, a flavonoid 3'-hydroxylase or a functional derivative thereof. The present invention also relates to transgenic plants carrying and/or expressing the above-mentioned nucleic acid material.
Patent NZ-257926-A (NZ)
Title: Absorbent structure in an absorbent article has cellulose fibres dry-formed to a web with a weight per unit area of between 30-1000 g/m2
Inventor: WIDLUND URBAN
IPC: A61F13/20
Filed: 1993-11-15
Abstract: PCT No. PCT/SE93/00973 Sec. 371 Date Aug. 2, 1995 Sec. 102(e) Date Aug. 2, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/10955 PCT Pub. Date May 26, 1994A method for the manufacturing of an absorbent structure in an absorbent article, such as a sanitary napkin, tampon, panty protector, wound or sore dressing and like articles is produced by using absorbent material in roll form directly in the product without first defibrating the material and then forming a mat. The material possesses good dispersion properties and swelling properties, which are meaningful to the function of the product. A high surface dryness is obtained, among other things. In addition to cellulose fibers, the absorbent structure may also include superabsorbent material and/or binding fibers, among other ingredients. The pulp mat is very thin, therewith obviating the need to compress the mat further in the product. In the case of certain product applications, the material is softened mechanically prior to its use as an absorbent material.
Patent NZ-283376-A (NZ)
Title: Push button metering device for dispensing constant unit doses
Inventor: BODIN JACQUES
IPC: G01F11/02
Filed: 1995-03-17
Abstract: PCT No. PCT/FR95/00325 Sec. 371 Date Nov. 21, 1995 Sec. 102(e) Date Nov. 21, 1995 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25945 PCT Pub. Date Sep. 28, 1995The metering device includes a hollow plunger (5) delimiting a defined volume, mounted so that it can move on a receptacle (1), and communicating with it, as well as an elastic member connecting the plunger to the receptacle, consisting of an elastically deformable cylindrical collar (8) including at least one valve (14) capable of closing off the outlet orifice of the receptacle, and fitted around a closed cylinder (6), having the same axis as the cylindrical collar, integral with the receptacle (1). Application to the administration of pharmaceutical products in fluid form.
Patent NZ-285984-A (NZ)
Title: Trigger device, enabling larger actuating force to be restrained by a smaller control force, and used for inflation of life jacket
Inventor: MCNAMEE JOHN BODEN
IPC: B63C9/22
Filed: 1995-05-29
Abstract: PCT No. PCT/AU95/00310 Sec. 371 Date Nov. 25, 1996 Sec. 102(e) Date Nov. 25, 1996 PCT Filed May 29, 1995 PCT Pub. No. WO95/32891 PCT Pub. Date Dec. 7, 1995A trigger device enabling a larger actuating force to be restrained by a smaller control force comprises a housing in which is rotatably mounted a primary lever biased to rotate from a cocked position to a firing position by a tension spring. The tension spring is located such that the rotational bias to the primary lever is significantly greater in the firing position than in the cocked position. The trigger device is typically used for both automatic and manual release of compressed gas from a bottle to an inflatable life-saving aid by way of a piercing pin moved by a cam surface on a secondary lever which can be manually rotated by a toggle or automatically by the primary lever on the dissolving of a water-soluble tablet restraining the primary lever in the cocked position.
Patent NZ-503203-A (NZ)
Title: Flue seal for a carbon anode baking furnace
Inventor: GIBSON DONALD B
IPC: F27D99/00
Filed: 1998-06-22
Abstract: A device for sealing a passageway in a flue from a carbon anode baking furnace, the flue being generally rectangular in shape and comprising a flue top (10) and bottom, a headwall (14) on either end of the flue, two walls, an opening in the flue top, at least one baffle, and a plurality of spacers (16) which are connected to both walls of the flue, the headwall, the two walls and the flue top define a headwall port which permits fluid passage between adjoining flues; the sealing device comprises: an inflatable bladder (2), a means to deliver air under pressure (4) connected to the inflatable bladder (2) by a seal to prevent air leakage between the means to deliver air pressure and the inflatable bladder; the inflatable bladder is long enough to extend from the flue top to a headwall (14) and seal off the communication between flues at the headwall port when inflated.
Patent NZ-503575-A (NZ)
Title: Assembly, for mounting an antenna to a roof, comprising a mast affixed to a bracket arm
Inventor: RICHARDS ROBERT JOHN
IPC: H01Q1/12
Filed: 2000-03-23
Abstract: A mast assembly, for mounting an antenna to a roof of a building, includes attachment means 15, to be secured to one or more  structural frame members 11 of the roof so as to lie contiguous with or in close proximity to the inner side of the fascia 12.  An outwardly extending rigid bracket arm 18 is secured to the attachment means 15.  The bracket arm is arranged so that it will extend across and beyond the upper edge of the fascia with its outer free end spaced a short distance therefrom.  An upstanding antenna support mast or post 19 is affixed to the bracket arm at or adjacent it outer free end.  The attachment means may comprise a pair of telescopically engaging tubular members 15 each of which is provided at its outer end with an attachment plate 16, 17.
Patent NZ-507462-A (NZ)
Title: A database useful for configuring and/or optimizing a system and a method for generating the database
Inventor: MOLLER GERT LYKKE SORENSEN
IPC: G06F17/50
Filed: 1999-03-16
Abstract: The system provides the ability to generate and use a database representing all solutions (legal combinations) satisfying all constraints of configuration problems on finite domains and/or intervals. The configuration space with all legal combinations is stored in a compact way in terms of nested arrays, where each legal Cartesian subspace has a unique index. Thus, the complete configuration space (which can be extended with object functions for optimisation) is easily addressable by parallel indexing techniques and the database is therefore suitable for run-time applications (e.g. configuration on the Internet), which must be performed in real time.
Patent NZ-516461-A (NZ)
Title: A frame assembly for security screens
Inventor: REID JIM
IPC: E06B9/52
Filed: 2000-05-30
Abstract: A frame assembly for security screens having at least two parts, including first and second parts, which together form a recess, a retaining means for retaining an edge of a generally planar member within the recess and urging means for increasing the force with which the retaining means retains an edge portion of the generally planar member.
Patent NZ-516658-A (NZ)
Title: Slide container characterised with integrally formed partitions to hold microscope slides for transport, wherein the container closes like a book
Inventor: HOPKINS ALISON
IPC: B65D5/481
Filed: 2002-01-18
Abstract: A microscope slide container (10) including a pair of covers (11,12), a hinge interconnecting the covers and a pair of bodies of resilient material, each body (25,26) being attached to a respective cover and having cavities (27) formed therein for the reception and retention of microscope slides.
Patent NZ-518373-A (NZ)
Title: High speed surface effect ship hull with air cushion venting prevention measures
Inventor: BARSUMIAN BRUCE R
IPC: B60V1/08
Filed: 2000-11-16
Abstract: A deep-V hull configuration for (2) a surface effect ship (SES) that utilizes a cushion of pressurized air and improves the handling characteristics and efficiency of the vessel is provided by the present invention. The surface effect vessel has an air cushion recess for containing the pressurized cushion of air that has a sloped transition area on a bow (10) side edge. Water redirecting structures (33, 35) on the deep-V hull direct a turbulent water flow toward blow through areas of the air cushion recess and, thus, prevent air from escaping from the air cushion recess. Multiple longitudinal and transverse air compartments (4, 6) are formed in the air cushion recess. Specialized separation portions (116) provide for restricted air communication between the multiple air compartments. Air is introduced into the multiple air compartments at independently adjustable pressures to facilitate turning and to adjust for various operating conditions. Specialized drive shafts and prop configurations (172, 182) are further utilized to improve the functioning of the surface effect vessel. The present invention may be utilized for fast marine transportation as well as various military applications.
Patent NZ-518912-A (NZ)
Title: A method and device for operating an electrolytic cell
Inventor: VESTRE SILJA BJERKE
IPC: C25C3/22
Filed: 2000-11-15
Abstract: The present invention concerns a method and device for reducing emissions of process gases from Hall-Héroult cells to the ambient air. The cells comprise an anode superstructure (1) with covers which can be opened for access to the cell's anodes, among other things. The anode superstructure comprises an extraction system for the removal of process gases, which extraction system is adjusted to remove a standardised quantity of process gases during normal operation of the cell. The extraction system is designed so that an increased quantity of process gases is removed when the covers of the anode superstructure are opened. One embodiment of the present invention includes a vertical partition wall (10') which is located inside the anode superstructure and contributes to an improved flow pattern in the anode superstructure.
Patent NZ-521890-A (NZ)
Title: A gradient based training method for a support vector machine
Inventor: KOWALCZYK ADAM
IPC: G06N20/10
Filed: 2001-04-11
Abstract: A training method for a support vector machine includes executing an iterative process on a training set of data to determine parameters defining the machine. The iterative process is executed on the basis of a differentiable form of a primal optimization problem for the parameters, the problem being defined on the basis of the parameters and the data set. The method is adapted for generation of a kernel learning machine or to generate a regularization network. The output of the support vector machine can be given as a linear function (y = w · x +bb) or its binarised form (y = sgn (w · x + bb) wherein x is the input data, y is the output data, b is 0 or 1 and w and b (bias) are parameters that define the decision surface and are obtained by minimizing a differentiable objective function as defined in the specification.
Patent NZ-528651-A (NZ)
Title: Glycosylated interferon gamma polypeptide variants
Inventor: JENSEN ANNE DAM
IPC: C12P21/02
Filed: 2002-04-04
Abstract: An interferon gamma (IFNG) S99T polypeptide variant which has a threonine at position 99 exhibiting IFNG activity and having the amino acid sequence shown in SEQ ID NO:1, or a carboxy (C-) terminally truncated fragment thereof exhibiting IFNG activity. Also described are other variants of the IFNG S99T polypeptide, expression vectors and host cells comprising the polypeptide and the use of the polypeptide variant in a pharmaceutical composition to treat interstitial pulmonary diseases.
Patent NZ-530973-A (NZ)
Title: Pharmaceutical formulation containing an LTB4 antagonist
Inventor: BOCK THOMAS
IPC: A61K31/27
Filed: 2002-07-09
Abstract: A pharmaceutical formulation containing an LTB4 antagonist of formula (I), wherein A, R1, R2, R3 and R4 have the designation cited in claim 1. The invention also relates to the use of said formulation as a pharmaceutical.
Patent NZ-533997-A (NZ)
Title: Amino alcohol derivatives
Inventor: NISHI TAKAHIDE
IPC: C07F7/18
Filed: 2001-07-10
Abstract: Disclosed is a process for the preparation of a compound of formula (XLIVa) or (XLIVb), Wherein: R1 and R2 are the same or different and each represents a hydrogen atom or an amino protecting group; R4a represents a C1-C20 alkyl group, a C2-C20 alkyl group interrupted with a heteroatom(s), a C1-C20 alkyl group substituted with an aryl group(s) or a heteroaryl group(s), a C2-C20 alkynyl group, a C3-C10 a group interrupted with a heteroatom(s), a C2-C20 alkynyl group substituted with an aryl group(s) or a heteroaryl group(s), a C2-C20 alkenyl group substituted with an aryl group(s) or a heteroaryl group(s), a C2-C20 alkyl group which is substituted with an aryl group(s) or a heteroaryl group(s) and interrupted with a heteroatom(s), or a cycloalkyl group; and R11 has the same meaning as that indicated above for R4a. Further disclosed is an isolated stereoisomer of formula (XLIVa) or (XLIVb) when obtained by a method according to the invention. (62) Divided out of 523554
Patent NZ-536711-A (NZ)
Title: Rotary selector switch
Inventor: BIERSACK HORST
IPC: F16H59/04
Filed: 2004-11-22
Abstract: The cam 13 is concentrically mounted to rotary switch 12 and engages in the groove 14 so that when the switch is rotated the cam moves the tube 5 in either axial direction so that one set or the other of splines 6 or 10 is engaged by the tube for different operating modes of a portable drill driven by gear 1 and ring gear 3. Sometimes the splines cannot immediately engage in the corresponding slots. To accommodate this, the cam is mounted on the end of a shaft that is mounted to a spring biased wobble plate so that the cam can pivot under bias in an orbital motion. As soon as the splines can engage the slots the tube will be moved axially under the influence of the biased cam.
Patent NZ-539395-A (NZ)
Title: Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
Inventor: HOFFEE MARY G
IPC: C12N5/06
Filed: 2003-11-05
Abstract: Disclosed are anti-CD33 antibodies, fragments and homologues of said antibodies, humanized and resurfaced versions of said antibodies, and functional equivalents of said antibodies, immunoconjugates and compositions comprising said antibodies, and the uses of same in diagnostic, research and therapeutic applications. Also disclosed is a polynucleotide encoding the antibodies, vectors comprising the polynucleotides, host cells transformed with polynucleotides and methods of producing the antibodies.
Patent NZ-544378-A (NZ)
Title: Process for the synthesis of high purity norgestrel 3-one-oxime
Inventor: TUBA ZOLTAN
IPC: C07J41/00
Filed: 2004-04-29
Abstract: Process for the synthesis of high purity d-(17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yne-3-one-oxime via acetylation of d-norgestrel at position 17, oximation of the oxo group at position 3 of the obtained 17-acetoxy derivative, and finally hydrolyzing the acetoxy group at position 17 of the obtained 3-oxime derivative, comprising the steps of carrying out the acetylation of the starting material, d-(17alpha)-17-hydroxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one (d-norgestrel) - purity at least 93-94% -, with acetic anhydride in acetic acid, in the presence of zinc chloride and hydrogen chloride, or 70 % perchloric acid in an inert gas atmosphere, and after completion of the reaction decomposing the excess of acetic anhydride and the "enol acetate" by-product with aqueous hydrochloric acid, then isolating the formed d-(17alpha)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one from the reaction mixture by addition of ice-water, filtering off the precipitated product, washing with water, drying, dissolving in dichloromethane or acetone and clarifying with silica gel or aluminium oxide and charcoal, concentrating the resulted solution after filtration of the clarifier and recrystallizing the residue, reacting the obtained d-(17alpha)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one either with hydroxylammonium acetate or with hydroxylammonium chloride in the presence of sodium acetate, in acetic acid in nitrogen atmosphere under vigorous stirring for about 1 hour, addition of water after completion of the reaction, filtering off the precipitated product, washing with water, drying and recrystallizing, hydrolyzing the obtained d-(17alpha)-17-acetoxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one-oxime with an equivalent amount of an alkali metal hydroxide in a C1-C4 alkanol solution, in nitrogen atmosphere between a temperature of about 5-38 deg C, under vigorous stirring, diluting the reaction mixture with water after completion of the reaction and adjusting the pH of the resulted suspension to 7.5-9 with acetic acid, filtering off the precipitated product, washing with water, drying, dissolving the crude product in ethanol, clarifying with charcoal, and addition of water after filtration of the clarifier to the obtained solution, filtering off the precipitated high purity d-(17alpha)-17-hydroxy-13-ethyl-18,19-dinorpregn-4-ene-20-yne-3-one-oxime, washing with water and in given case recrystallizing from ethanol.
Patent NZ-552448-A (NZ)
Title: High performance load resistor
Inventor: WOBBEN ALOYS
IPC: H01C3/10
Filed: 2005-07-08
Abstract: A high-performance resistor is provided. The resistor includes a number of straight resistor elements which are electrically connected in series and each having a first and a second side and a first and a second end. At the first end is a first connection and at the second end is a second connection for releasable connection of adjacent resistor elements. The first and second connections each have an inner portion and an outer portion, where the inner portion of the first connection is bent at an angle with respect to the first side of the resistor element and the outer portion of the first connection projects beyond the resistor element by a dimension and is in a plane which is substantially parallel to the plane of the resistor element. The inner portion of the second connection is bent at an angle with respect to the second side of the resistor element and the outer portion of the second connection projects beyond the resistor element by a dimension and is in a plane which is substantially parallel to the plane of the resistor element. Adjacent resistor elements are releasably and electrically connected together by way of their outer portions of the first and second connections. The first connection is displaced by a first dimension with respect to the longitudinal axis of the resistor element and the second connection is displaced by a second dimension with respect to the longitudinal axis of the resistor element.
Patent NZ-555289-A (NZ)
Title: Inhibitors of c-fms kinase
Inventor: ILLIG CARL R
IPC: A61K31/44
Filed: 2005-10-20
Abstract: Disclosed is a aromatic amide compound of Formula I or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof, wherein, A is phenyl or pyridyl, W is pyrrolyl, imidazolyl, 1,2,4 triazolyl, or furanyl, any of which may be connected through any carbon atom to any other carbon of cycloalkyl, thiophenyl, dihydrosulfonopyranyl, tetrahydropyridyl or dihydropyranyl, X is defined as in the specification, R3 is hydrogen, hydroxyalkylamino, (hydroxyalkyl)2 amino, alkylamino, aminoalkyl, dihydroalkyl, alkoxy, dialkylamino, hydroxyalkyl, -COOH, - CONH2, - CN, -SO2-alkyl-R3, -amino, or a 5 or 6 membered ring which contains at least 1 nitrogen and R4 is hydrogen, -OH, alkoxy, carboxy, carboxamido or carbomoyl. Also disclosed are compositions comprising said compound, a dosage form comprising said compound, the use of said compound for the manufacture of a medicament for the treatment of cancer, inflammation or cardiovascular diseases.
Patent NZ-555443-A (NZ)
Title: Vertical door locking system with a latch including a latchbolt that is movable relative to the door
Inventor: SLUSARSKI RONALD S
IPC: E05B15/02
Filed: 2005-10-19
Abstract: A locking system for a vertical door (12) is disclosed. The system includes a sliding latch (10) mounted to the door (12) that and an electrically operated solenoid (14) mounted at a fixed location on a guide rail (18) for the door (12) or the door frame. The latch includes a movable latch bolt (20) that extends outward from the door (12) to prevent the door (12) from being raised vertically and the latch bolt (20) has an opening at one end. The solenoid (14) includes a spring operated solenoid rod that extends into the opening in the latch bolt (20) to prevent the latch bolt (20) from being retracted thereby preventing the door (12) from being opened unless the solenoid (14) is electrically operated to disengage the solenoid rod and release the latch bolt (20).
Patent NZ-571020-A (NZ)
Title: Device enabling women to urinate in standing posture like men
Inventor: KHAMBATTA YAZDIYAR M
Filed: 2008-09-05
Abstract: A compact portable device that enables women to urinate in a standing posture like men, is disclosed. The compact portable device is held against the urethra opening, within the folds of Labia Minora, and does not cover the vaginal passage opening or the pubic area. The compact portable device includes a locator element, an absorbing seal element, a shell element, and a tube element. The locator element locates the device on the urethra opening, to direct the flow of urine away from the urethra opening, with minimal or no leakage to the surrounding area. The absorbing seal element is made of highly absorbent material, which forms a tight surface contact seal with the wall of Labia Minora, and is able to absorb any leakage past the locator element. The shell element is shaped to cover the surface of the absorbing seal element, and faces away from the urethra.
Patent NZ-583688-A (NZ)
Title: Dosage regime for the treatment of dementia using a VLP and amyloid-beta-1-42 peptide
Inventor: STAUFENBIEL MATTHIAS
IPC: A61K39/00
Filed: 2005-11-03
Abstract: Disclosed is the use of a construct comprising a virus-like particle (VLP) structure chemically coupled to a fragment of the Ab-1-42 peptide, or a pharmaceutically acceptable salt thereof, for the manufacture of a pharmaceutical composition for the prevention or treatment of dementia in humans, wherein the pharmaceutical composition is formulated for subcutaneous administration at a dose of 150 ìg to 1000 ìg of the construct about every 4 to 8 weeks, and wherein the fragment of Ab-1-42 peptide is Ab-1-6 peptide.
Patent NZ-585996-A (NZ)
Title: Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
Inventor: DEMONT EMMANUEL HUBERT
IPC: A61K31/55
Filed: 2008-12-19
Abstract: Disclosed are oxadiazole derivatives represented by general formula (I) such as -(5-{ 3-chloro-4-[( 1-methylethyl)oxy]phenyl} -1,2,4-oxadiazol-3-yl)-2,3,4,5-tetrahydro-1H-2-benzazepine and [7-(5-{ 3-chloro-4-[(1-methylethyl)oxy]phenyl} -1,2,4-oxad iazol-3-yl )-1,3,4,5-tetrahydro-2H-2-benzazepin-2-yl]acetic acid. The compounds of formula (I) are used to treat conditions or diseases mediated by S1P1 receptors such as multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis, ischemia-reperfusion injury, solid tumours, and tumour metastasis, diseases associated with angiogenesis, vascular diseases, pain conditions, acute viral diseases, inflammatory bowel conditions, insulin and non-insulin dependant diabetes.
Patent NZ-590033-A (NZ)
Title: Interleukin-1alpha antibodies and methods of use
Inventor: SIMARD JOHN
IPC: C12N5/09
Filed: 2009-06-01
Abstract: Provided is a purified human IgG1 monoclonal antibody (mAb) that specifically binds to human IL-1a, the mAb comprising a heavy chain covalently joined to a light chain, wherein the heavy and light chain each comprises a specified amino acid sequence. The antibody can be used to treat a disease caused by increased E-selection expressed on human endothelial cells.